Charles River Laboratories International, Inc. Share Price
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
151.99 USD | -0.77% |
|
-7.20% | -17.67% |
Capitalization | 777.22Cr 739.91Cr 697.86Cr 616.35Cr 1.1TCr 67TCr 1.22TCr 8.31TCr 3.08TCr 28TCr 2.91TCr 2.85TCr 1,18200Cr | P/E ratio 2024 * |
26.1x | P/E ratio 2025 * | 27.1x |
---|---|---|---|---|---|
Enterprise value | 987.87Cr 940.45Cr 886.99Cr 783.4Cr 1.4TCr 86TCr 1.55TCr 11TCr 3.91TCr 36TCr 3.7TCr 3.63TCr 1,50200Cr | EV / Sales 2024 * |
2.45x | EV / Sales 2025 * | 2.41x |
Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Charles River Laboratories International, Inc.
1 day | -0.77% | ||
1 week | -7.20% | ||
Current month | -7.75% | ||
1 month | -12.60% | ||
3 months | -19.04% | ||
6 months | -24.79% | ||
Current year | -17.67% |







Director | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 74 | 01/01/1992 |
Flavia Pease
DFI | Director of Finance/CFO | 52 | 01/05/2022 |
Julie Frearson
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2014 |
Manager | Title | Age | Since |
---|---|---|---|
George Massaro
BRD | Director/Board Member | 77 | 01/01/2003 |
James Foster
CHM | Chairman | 74 | 01/01/2000 |
Deborah Kochevar
BRD | Director/Board Member | 68 | 29/10/2008 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.05% | 1 M€ | 0.00% | - | |
2.07% | 0 M€ | -1.80% | - | |
1.08% | 0 M€ | 0.00% | - | |
0.98% | 0 M€ | 0.00% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.77% | -7.20% | -38.06% | -51.38% | 777.22Cr | ||
-0.43% | -1.39% | +28.71% | -1.26% | 4.79TCr | ||
-1.33% | -7.06% | -19.89% | -15.40% | 3.41TCr | ||
-0.45% | -1.71% | -0.38% | +22.57% | 2.66TCr | ||
+0.04% | +6.58% | +72.73% | +81.40% | 1.65TCr | ||
+1.95% | -3.75% | -35.82% | -23.17% | 1.54TCr | ||
+6.79% | +29.70% | - | - | 1.41TCr | ||
+3.35% | +1.20% | -63.80% | -78.17% | 1.27TCr | ||
-1.12% | -9.44% | -7.47% | -36.10% | 1.04TCr | ||
-0.65% | -3.93% | -13.74% | +144.96% | 1.04TCr | ||
Average | +0.74% | +0.38% | -8.64% | +4.83% | 1.96TCr | |
Weighted average by Cap. | +0.34% | -0.22% | +0.08% | +4.08% |
2024 * | 2025 * | |
---|---|---|
Net sales | 403.11Cr 383.76Cr 361.94Cr 319.67Cr 571.12Cr 35TCr 633.76Cr 4.31TCr 1.6TCr 15TCr 1.51TCr 1.48TCr 61TCr | 390.55Cr 371.81Cr 350.67Cr 309.72Cr 553.34Cr 34TCr 614.03Cr 4.18TCr 1.55TCr 14TCr 1.46TCr 1.43TCr 59TCr |
Net income | 30Cr 29Cr 27Cr 24Cr 43Cr 2.61TCr 47Cr 322.02Cr 119.3Cr 1.09TCr 112.91Cr 110.64Cr 4.58TCr | 29Cr 27Cr 26Cr 23Cr 40Cr 2.47TCr 45Cr 304.74Cr 112.9Cr 1.03TCr 106.85Cr 104.7Cr 4.33TCr |
Net Debt | 210.65Cr 200.54Cr 189.14Cr 167.05Cr 298.45Cr 18TCr 331.18Cr 2.25TCr 834.33Cr 7.63TCr 789.65Cr 773.75Cr 32TCr | 165.6Cr 157.65Cr 148.69Cr 131.32Cr 234.62Cr 14TCr 260.35Cr 1.77TCr 655.89Cr 6TCr 620.77Cr 608.27Cr 25TCr |
Date | Price | Change | Volume |
---|---|---|---|
14/25/14 | 151.99 $ | -0.77% | 841,132 |
13/25/13 | 153.17 $ | -0.54% | 901,107 |
12/25/12 | 154.00 $ | -0.58% | 1,278,385 |
11/25/11 | 154.90 $ | -3.12% | 946,154 |
10/25/10 | 159.89 $ | -2.38% | 1,709,860 |
Delayed Quote Nyse, February 15, 2025 at 02:30 am IST
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CRL Stock

MarketScreener is also available in this country: United States.
Switch edition